ARCHIVES

CCOP Success Acknowledged, Recompetition Plans Being Made; Cancer Control May Be Added To RFA

This article is from The Cancer Letter archive.

Vol. 12 No. 15 | April 11, 1986

Download PDF Visit The Full Archive

Related Articles

CIS Cost Sharing Feasibility Study Recommended

December 11, 1987

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001

Fisher, interim NSABP Leadership Enter Third Day Of Negotiations To Settle Suit, Aver Court Battle

September 30, 1994

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

July 14, 1995